XAIR / Beyond Air: Dilution Remains A Concern

GARDEN CITY, N.Y. and HAMILTON, Bermuda, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Beyond Cancer, Ltd., an affiliate of Beyond Air, Inc. (NASDAQ: XAIR) that i more_horizontal

Beyond Air, Inc. (NASDAQ:XAIR ) Q1 2024 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Edward Barger - Head of Investor Rela more_horizontal

Beyond Air, Inc. (XAIR) came out with a quarterly loss of $0.45 per share versus the Zacks Consensus Estimate of a loss of $0.46. This compares to los more_horizontal

Today, we take a look at an interesting small-cap medical device concern called Beyond Air, Inc. The company is just rolling out its first approved pr more_horizontal

Beyond Air, Inc. (NASDAQ:XAIR ) Q4 2023 Earnings Conference Call June 22, 2023 4:30 PM ET Company Participants Edward Barger - Head of Investor Relati more_horizontal

Beyond Air, Inc. (XAIR) came out with a quarterly loss of $0.67 per share versus the Zacks Consensus Estimate of a loss of $0.44. This compares to los more_horizontal

GARDEN CITY, N.Y., May 16, 2023 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a commercial stage medical device and biopharmaceutical company f more_horizontal

According to the Insider Cluster Buys Screen, a Premium feature of GuruFocus, five stocks that have high number of unique insider buys over the past t more_horizontal